Institutions / Mitsubishi UFJ Asset Management Co., Ltd. / Activity
Activity — Mitsubishi UFJ Asset Management Co., Ltd.
101 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q2 2026 as of | New | G9600F104 Common stock | $5.7K | +136 | 136 <0.01% of portfolio | low |
| Q2 2026 as of | New | Clearway Energy, Inc. Common stock | $6.8K | +198 | 198 <0.01% of portfolio | low |
| Q2 2026 as of | New | Versant Media Group, Inc. Common stock | $10.9K | +302 | 302 <0.01% of portfolio | low |
| Q2 2026 as of | New | Bank OZK Common stock | $14.2K | +273 | 273 <0.01% of portfolio | low |
| Q2 2026 as of | New | M46528101 Common stock | $14.4K | +415 | 415 <0.01% of portfolio | low |
| Q2 2026 as of | New | ACT Enact Holdings, Inc. Common Stock | $14.4K | +316 | 316 <0.01% of portfolio | low |
| Q2 2026 as of | New | CNA Cna Financial Corp Common Stock | $16.2K | +334 | 334 <0.01% of portfolio | low |
| Q2 2026 as of | New | Satellogic Inc. Common stock | $21.7K | +4K | 3,800 <0.01% of portfolio | low |
| Q2 2026 as of | New | G0378L100 Common stock | $23.5K | +291 | 291 <0.01% of portfolio | low |
| Q2 2026 as of | New | CXDO Crexendo, Inc. Common Stock | $23.6K | +3K | 3,158 <0.01% of portfolio | low |
| Q2 2026 as of | New | EVMN Evommune, Inc. Common Stock | $23.9K | +2K | 1,800 <0.01% of portfolio | low |
| Q2 2026 as of | New | Wolfspeed, Inc. Common stock | $28.9K | +600 | 600 <0.01% of portfolio | low |
| Q2 2026 as of | New | SFD Smithfield Foods Inc Common Stock | $29.0K | +1K | 1,189 <0.01% of portfolio | low |
| Q2 2026 as of | New | YUMC Yum China Holdings, Inc. Common Stock | $29.3K | +715 | 715 <0.01% of portfolio | low |
| Q2 2026 as of | New | Laureate Education, Inc. Common stock | $29.8K | +797 | 797 <0.01% of portfolio | low |
| Q2 2026 as of | New | PPC Pilgrims Pride Corp Common Stock | $30.4K | +1K | 1,065 <0.01% of portfolio | low |
| Q2 2026 as of | New | Levi Strauss & Co Common stock | $30.5K | +1K | 1,246 <0.01% of portfolio | low |
| Q2 2026 as of | New | G8588X103 Common stock | $30.8K | +2K | 2,204 <0.01% of portfolio | low |
| Q2 2026 as of | New | REYN Reynolds Consumer Products Inc. Common Stock | $31.0K | +1K | 1,141 <0.01% of portfolio | low |
| Q2 2026 as of | New | Piper Sandler Cos Common stock | $36.2K | +500 | 500 <0.01% of portfolio | low |
| Q2 2026 as of | New | Lincoln Educational Services Corporation Common stock | $39.9K | +800 | 800 <0.01% of portfolio | low |
| Q2 2026 as of | New | Copa Holdings, S.A. Common stock | $42.8K | +278 | 278 <0.01% of portfolio | low |
| Q2 2026 as of | New | G02602103 Common stock | $42.8K | +840 | 840 <0.01% of portfolio | low |
| Q2 2026 as of | New | Cnb Financial CORP/PA Common stock | $43.8K | +1K | 1,300 <0.01% of portfolio | low |
| Q2 2026 as of | New | Sionna Therapeutics, Inc. Common stock | $44.0K | +1K | 1,000 <0.01% of portfolio | low |
| Q2 2026 as of | New | LBRX Lb Pharmaceuticals Inc Common Stock | $45.4K | +1K | 1,400 <0.01% of portfolio | low |
| Q2 2026 as of | New | Maze Therapeutics, Inc. Common stock | $47.7K | +2K | 1,600 <0.01% of portfolio | low |
| Q2 2026 as of | New | Corvus Pharmaceuticals, Inc. Common stock | $47.8K | +3K | 3,200 <0.01% of portfolio | low |
| Q2 2026 as of | New | G6375R107 Common stock | $47.9K | +2K | 1,600 <0.01% of portfolio | low |
| Q2 2026 as of | New | VIA Via Transportation, Inc. Common Stock | $49.0K | +3K | 2,700 <0.01% of portfolio | low |
| Q2 2026 as of | New | Veradermics, Inc Common stock | $49.2K | +400 | 400 <0.01% of portfolio | low |
| Q2 2026 as of | New | 11285B108 Common stock | $49.2K | +1K | 1,326 <0.01% of portfolio | low |
| Q2 2026 as of | New | AIP Arteris, Inc. Common Stock | $53.4K | +1K | 1,100 <0.01% of portfolio | low |
| Q2 2026 as of | New | GDS GDS Holdings Ltd ADR | $55.0K | +2K | 1,830 <0.01% of portfolio | low |
| Q2 2026 as of | New | 077347201 Common stock | $58.2K | +200 | 200 <0.01% of portfolio | low |
| Q2 2026 as of | New | MYR Group Inc. Common stock | $69.6K | +139 | 139 <0.01% of portfolio | low |
| Q2 2026 as of | New | M7S750159 Common stock | $71.3K | +1K | 1,088 <0.01% of portfolio | low |
| Q2 2026 as of | New | Sellas Life Sciences Group Inc Common stock | $76.8K | +5K | 5,200 <0.01% of portfolio | low |
| Q2 2026 as of | New | ALT5 Sigma Corp Common stock | $94.6K | +162K | 161,651 <0.01% of portfolio | low |
| Q2 2026 as of | New | OWLT Owlet, Inc. Common Stock | $156.3K | +27K | 27,238 <0.01% of portfolio | low |
| Q2 2026 as of | New | G0593M107 Common stock | $168.2K | +887 | 887 <0.01% of portfolio | low |
| Q2 2026 as of | New | WisdomTree, Inc. Common stock | $171.3K | +10K | 10,112 <0.01% of portfolio | low |
| Q2 2026 as of | New | Customers Bancorp, Inc. Common stock | $176.7K | +2K | 2,234 <0.01% of portfolio | low |
| Q2 2026 as of | New | NCR Voyix Corp Common stock | $198.5K | +24K | 24,296 <0.01% of portfolio | low |
| Q2 2026 as of | New | KYTX Kyverna Therapeutics, Inc. Common Stock | $229.4K | +26K | 25,741 <0.01% of portfolio | low |
| Q2 2026 as of | New | FRMI Fermi Inc. Common Stock | $229.9K | +25K | 25,100 <0.01% of portfolio | low |
| Q2 2026 as of | New | FRVO Fervo Energy Co Common Stock | $230.9K | +8K | 7,900 <0.01% of portfolio | low |
| Q2 2026 as of | New | Qiagen N.V. Common stock | $255.7K | +7K | 6,540 <0.01% of portfolio | low |
| Q2 2026 as of | New | BKKT Bakkt, Inc. Common Stock | $257.1K | +33K | 32,917 <0.01% of portfolio | low |
| Q2 2026 as of | New | ClearPoint Neuro, Inc. Common stock | $261.4K | +15K | 14,655 <0.01% of portfolio | low |